Risk factors of retained CBD stone after ERCP with stent and cholecystectomy

Incidence of retain common bile duct stone after ERCP with stent

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220419009

Enrollment

100

Registered

2022-04-19

Start date

2022-04-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retained CBD stone common bile duct stone choledocholithiasis biliary stent endoscopic retrograde cholangiopancreatography ERCP cholecystectomy

Interventions

patients presented with CBD stone, then underwent ERCP with stone removal and stent placement followed by cholecystectomy

Treatment

post-ERCP and post-cholecystectomy

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) age 18-90 years, 2) ERCP initially performed for stone removal with stent placement, 3) followed by open or laparoscopic cholecystectomy after initial ERCP, 4) ERCP finally proceeded for stent removal after cholecystectomy

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
retained CBD stone at ERCP after cholecystectomy ERCP finding of CBD stone	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactAssanee Tongyoo

Faculty of Medicine, Thammasat University

assaneetongyoo@gmail.com0839915546

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026